{"id":2652,"date":"2019-05-01T15:50:12","date_gmt":"2019-05-01T13:50:12","guid":{"rendered":"https:\/\/www.rcts.fr\/uncategorized\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial"},"modified":"2025-12-04T11:37:45","modified_gmt":"2025-12-04T10:37:45","slug":"closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial","status":"publish","type":"post","link":"https:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/","title":{"rendered":"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial"},"content":{"rendered":"<p>Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1<br \/>\ndiabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas<br \/>\nsystem improved glucose control compared with sensor-assisted pump therapy.<\/p>\n<p><a href=\"https:\/\/www.thelancet.com\/action\/showPdf?pii=S2589-7500%2819%2930003-2\" rel=\"noopener noreferrer\" target=\"_blank\">Mai 2019 \u00b7 Lancet Digital Health<\/a><\/p>\n<p>Pierre-Yves Benhamou, Sylvia Franc, Yves Reznik, Charles Thivolet, Pauline Schaepelynck, Eric Renard, Bruno Guerci, Lucy Chaillous, Celine Lukas-Croisier, Nathalie Jeandidier, Helene Hanaire, Sophie Borot, Maeva Doron, Pierre Jallon, Ilham Xhaard, Vincent Melki, Laurent Meyer, Brigitte Delemer, Marie Guillouche, Laurene Schoumacker-Ley, Anne Farret, Denis Raccah, Sandrine Lablanche, Michael Joubert, Alfred Penfornis, Guillaume Charpentier, on behalf of the DIABELOOP WP7 Trial Investigators*<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system improved glucose control compared with sensor-assisted pump therapy. Mai 2019 \u00b7 Lancet Digital Health Pierre-Yves Benhamou, Sylvia Franc, Yves Reznik, Charles Thivolet, Pauline [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":7699,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false},"categories":[58],"class_list":["post-2652","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diabetes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial - RCTs<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial - RCTs\" \/>\n<meta property=\"og:description\" content=\"Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system improved glucose control compared with sensor-assisted pump therapy. Mai 2019 \u00b7 Lancet Digital Health Pierre-Yves Benhamou, Sylvia Franc, Yves Reznik, Charles Thivolet, Pauline [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"RCTs\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-01T13:50:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-04T10:37:45+00:00\" \/>\n<meta name=\"author\" content=\"Didier Not\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Didier Not\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/#article\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/\"},\"author\":{\"name\":\"Didier Not\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\"},\"headline\":\"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial\",\"datePublished\":\"2019-05-01T13:50:12+00:00\",\"dateModified\":\"2025-12-04T10:37:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/\"},\"wordCount\":121,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\"},\"image\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/vignette-580x430-18.svg\",\"articleSection\":[\"Diabetes\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/\",\"name\":\"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial - RCTs\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/#primaryimage\"},\"image\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/vignette-580x430-18.svg\",\"datePublished\":\"2019-05-01T13:50:12+00:00\",\"dateModified\":\"2025-12-04T10:37:45+00:00\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/vignette-580x430-18.svg\",\"contentUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/vignette-580x430-18.svg\",\"width\":434,\"height\":322,\"caption\":\"Closed-loop insulin\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rcts.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/\",\"name\":\"RCTs\",\"description\":\"Description\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rcts.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\",\"name\":\"RCTs\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"contentUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"width\":163,\"height\":47,\"caption\":\"RCTs\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\",\"name\":\"Didier Not\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"caption\":\"Didier Not\"},\"url\":\"https:\\\/\\\/www.rcts.fr\\\/en\\\/author\\\/dnorcts-fr\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial - RCTs","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/","og_locale":"en_US","og_type":"article","og_title":"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial - RCTs","og_description":"Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system improved glucose control compared with sensor-assisted pump therapy. Mai 2019 \u00b7 Lancet Digital Health Pierre-Yves Benhamou, Sylvia Franc, Yves Reznik, Charles Thivolet, Pauline [&hellip;]","og_url":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/","og_site_name":"RCTs","article_published_time":"2019-05-01T13:50:12+00:00","article_modified_time":"2025-12-04T10:37:45+00:00","author":"Didier Not","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Didier Not","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/#article","isPartOf":{"@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/"},"author":{"name":"Didier Not","@id":"https:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5"},"headline":"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial","datePublished":"2019-05-01T13:50:12+00:00","dateModified":"2025-12-04T10:37:45+00:00","mainEntityOfPage":{"@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/"},"wordCount":121,"commentCount":0,"publisher":{"@id":"https:\/\/www.rcts.fr\/#organization"},"image":{"@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/vignette-580x430-18.svg","articleSection":["Diabetes"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/","url":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/","name":"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial - RCTs","isPartOf":{"@id":"https:\/\/www.rcts.fr\/#website"},"primaryImageOfPage":{"@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/#primaryimage"},"image":{"@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/vignette-580x430-18.svg","datePublished":"2019-05-01T13:50:12+00:00","dateModified":"2025-12-04T10:37:45+00:00","breadcrumb":{"@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/#primaryimage","url":"https:\/\/www.rcts.fr\/wp-content\/uploads\/vignette-580x430-18.svg","contentUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/vignette-580x430-18.svg","width":434,"height":322,"caption":"Closed-loop insulin"},{"@type":"BreadcrumbList","@id":"http:\/\/www.rcts.fr\/en\/closed-loop-insulin-delivery-in-adults-with-type-1-diabetes-in-real-life-conditions-a-12-week-multicentre-open-label-randomised-controlled-crossover-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rcts.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial"}]},{"@type":"WebSite","@id":"https:\/\/www.rcts.fr\/#website","url":"https:\/\/www.rcts.fr\/","name":"RCTs","description":"Description","publisher":{"@id":"https:\/\/www.rcts.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rcts.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rcts.fr\/#organization","name":"RCTs","url":"https:\/\/www.rcts.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rcts.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","contentUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","width":163,"height":47,"caption":"RCTs"},"image":{"@id":"https:\/\/www.rcts.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5","name":"Didier Not","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","caption":"Didier Not"},"url":"https:\/\/www.rcts.fr\/en\/author\/dnorcts-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/comments?post=2652"}],"version-history":[{"count":3,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2652\/revisions"}],"predecessor-version":[{"id":7702,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/2652\/revisions\/7702"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/media\/7699"}],"wp:attachment":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/media?parent=2652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/categories?post=2652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}